Single-step functional coatings for increased efficiencies

Nathan Dormer; Cory Berkland

Single-step functional coatings for increased efficiencies

Nathan Dormer
, Cory Berkland

Research output: Contribution to specialist publication › Article

Abstract

In this article about oral drug innovation, Cory Berkland, PhD, Co-Founder & Chief Scientific Officer, and Nathan Dormer, PhD, Vice-President of Research & Development, both of Orbis Biosciences, focus on how enterics and reverse enterics are applied into dosage forms, and discuss the future of this class of drug formulation technology.

Original language	English
Pages	28-31
Number of pages	4
Volume	2017
No	77
Specialist publication	ONdrugDelivery
State	Published - 2017

Cite this

@misc{db97b6be24444f0da7580b3ac0ec635e,

title = "Single-step functional coatings for increased efficiencies",

abstract = "In this article about oral drug innovation, Cory Berkland, PhD, Co-Founder \& Chief Scientific Officer, and Nathan Dormer, PhD, Vice-President of Research \& Development, both of Orbis Biosciences, focus on how enterics and reverse enterics are applied into dosage forms, and discuss the future of this class of drug formulation technology.",

author = "Nathan Dormer and Cory Berkland",

note = "Publisher Copyright: {\textcopyright} 2017 Frederick Furness Publishing Ltd.",

year = "2017",

language = "English",

volume = "2017",

pages = "28--31",

journal = "ONdrugDelivery",

issn = "2049-145X",

}

TY - GEN

T1 - Single-step functional coatings for increased efficiencies

AU - Dormer, Nathan

AU - Berkland, Cory

PY - 2017

Y1 - 2017

N2 - In this article about oral drug innovation, Cory Berkland, PhD, Co-Founder & Chief Scientific Officer, and Nathan Dormer, PhD, Vice-President of Research & Development, both of Orbis Biosciences, focus on how enterics and reverse enterics are applied into dosage forms, and discuss the future of this class of drug formulation technology.

AB - In this article about oral drug innovation, Cory Berkland, PhD, Co-Founder & Chief Scientific Officer, and Nathan Dormer, PhD, Vice-President of Research & Development, both of Orbis Biosciences, focus on how enterics and reverse enterics are applied into dosage forms, and discuss the future of this class of drug formulation technology.

UR - https://www.scopus.com/pages/publications/85025169281

M3 - Article

AN - SCOPUS:85025169281

SN - 2049-145X

VL - 2017

SP - 28

EP - 31

JO - ONdrugDelivery

JF - ONdrugDelivery

ER -

Single-step functional coatings for increased efficiencies

Abstract

Other files and links

Fingerprint

Cite this